Recommendations for Bivalent COVID-19 Booster Doses in People Ages 12 Years and Older

At a glance

During this COCA Call, presenters will discuss CDC’s new guidance on bivalent COVID-19 booster doses for people ages 12 years and older, including those who are moderately or severely immunocompromised.

Webinar

The fully captioned video and edited transcript will be posted within the next few days.

View slides
View transcript

Overview

During this COCA Call, presenters will discuss CDC's new guidance on bivalent COVID-19 booster doses for people ages 12 years and older, including those who are moderately or severely immunocompromised. COVID-19 vaccination provides protection against serious illness and outcomes associated with COVID-19, including emergency department or urgent care visits, hospitalizations, and death. Updated COVID-19 vaccines add an Omicron BA.4/5 spike protein component to the previous monovalent composition. These bivalent booster doses help restore protection that has waned since previous vaccination by targeting more transmissible and immune-evading variants. These boosters also broaden the spectrum of variants that the immune system is ready to respond to.

Presenters

Sara Oliver, MD, MSPH
CDR, U.S. Public Health Service
Lead, COVID-19 Coordinating Unit
COVID-19
Response Centers for Disease Control and Prevention

Elisha Hall, PhD, RD
Lead, Clinical Guidelines, Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention

Evelyn Twentyman, MD, MPH
Lead, COVID-19 Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention

Anne M. Hause, PhD, MSPH
v-safe Team Co-lead, Immunization Safety Office
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention

Call Objectives

COCA Call Objectives

  1. Cite background information on the topic covered during the presentation.
  2. Discuss CDC's role in the topic covered during the presentation.
  3. Describe the topic's implications for clinicians.
  4. Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
  5. Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of healthcare providers.

Activity-specific Objectives

At the conclusion of the session, the participant will be able to accomplish the following:

  1. Discuss new recommendations for bivalent COVID-19 vaccines for people ages 12 years and older, including those who are moderately or severely immunocompromised.
  2. List key points for healthcare providers to use when discussing bivalent COVID-19 vaccines with patients.
  3. Describe where to find online resources for clinicians about bivalent COVID-19 vaccinations.

Additional Resource

Interim Clinical Considerations for Use of COVID-19 Vaccines

Vaccines.gov – Find COVID-19 vaccine locations near you

Web Resources to Help Prevent Vaccine Administration Errors:

Web Resources for the Public:

Web Resources for Immunization Partners:


Continuing Education

To receive continuing education (CE) for WC4520-091322 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Recommendations for Bivalent COVID-19 Booster Doses in People Ages 12 Years and Older, Tuesday, September 13, 2022, please visit TCEO and follow these 9 Simple Steps by Monday, October 17, 2022.

To receive continuing education (CE) for WD4520-091322 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Recommendations for Bivalent COVID-19 Booster Doses in People Ages 12 Years and Older, Tuesday, September 13, 2022, (Web on Demand), please visit TCEO and follow these 9 Simple Steps between Tuesday, October 18 2022, and Friday, October 18, 2024.

In support of improving patient care, the Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Jointly Accredited Provider logo
CDC is a Jointly Accredited Provider in Interprofessional Continuing Education.

CME: The Centers for Disease Control and Prevention designates this activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA CME: The Centers for Disease Control and Prevention has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid until 12/13/2023. PAs should only claim credit commensurate with the extent of their participation

CNE: The Centers for Disease Control and Prevention designates this activity for 1 nursing contact hours.

CPE: The Centers for Disease Control and Prevention designated this (Knowledge-based) event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is JA4008229-0000-22-122-L04-P and enduring is JA4008229-0000-22-123-H04-P.

Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 1. Continuing Competency credits available are 1. CDC provider number 98614.

AAVSB/RACE: This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program at race@aavsb.org if you have any comments/concerns regarding this program's validity or relevancy to the veterinary profession.

For Certified Public Health Professionals (CPH): The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credits for this program.

DISCLOSURE: In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.

CDC, our planners, and presenters wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use, with the exception of Dr. Elisha Hall, Dr. Sara Oliver and Dr. Evelyn Twentyman's discussion of discussion of vaccine use under Emergency Use Authorization or Emergency Use Instruction.

CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.

Target Audience

  • Physicians
  • Nurses
  • Pharmacists
  • Veterinarians
  • Physician Assistants
  • Health Educators
  • Other Clinicians

Additional Information

  • Contact Information: coca@cdc.gov
  • Support/Funding: Centers for Disease Control and Prevention, Emergency Risk Communication Branch
  • Method of Participation: You may participate in the educational activity by viewing the program information above.
Print
Content Source: